@prefix jvr: . @prefix skos: . @prefix mesh: . @prefix dc: . @prefix xsd: . @prefix owl: . jvr:-BT300B3G-Q skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-L6C0XPHT-4 skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NR94SJDS-1 skos:prefLabel "Enalapril"@en, "Énalapril"@fr ; a mesh:Descriptor, skos:Concept ; skos:narrower jvr:-P9LNTDXZ-L . jvr:-XV06LPML-W skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-FG8LP9J8-Q skos:prefLabel "Antihypertensive Agents"@en, "Antihypertenseurs"@fr ; a mesh:Descriptor, skos:Concept . jvr:-Q3979798-W skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-H7K65Q8S-Z skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-TJHVZCRZ-0 skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-G30ZJ446-J skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NFTHND7Q-8 skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-FWD2BGQ0-9 skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-THHNVC7V-3 skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-R0ZCQ8X6-J skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-S0CS1X5R-5 skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-M63HSDM7-1 skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-HQRFT0C6-B skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NB0XHT3S-N skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-W6SQV79N-S skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-CB30NGKB-3 skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-G4R176S9-J skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr: a skos:ConceptScheme . jvr:-SBNWSM1T-R skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-D0F21513-5 skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-R3QWLHRG-V skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NHL3D2X0-S skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-T9HQD7ST-J skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-P9LNTDXZ-L skos:altLabel "84680-54-6 (Enalaprilat)"@fr, "84680-54-6 (Enalaprilat)"@en, "GV0O7ES0R3"@fr, "GV0O7ES0R3"@en, "Q508Q118JM"@fr, "Q508Q118JM"@en, "84799-87-1 (cpd w/o stereochem designation, anhydrous)"@en, "84799-87-1 (cpd w/o stereochem designation, anhydrous)"@fr, "76391-23-6 ((R)-isomer, anhydrous)"@fr, "76391-23-6 ((R)-isomer, anhydrous)"@en, "L-Proline, N-((1S)-1-carboxy-3-phenylpropyl)-L-alanyl-"@fr, "L-Proline, N-((1S)-1-carboxy-3-phenylpropyl)-L-alanyl-"@en, "94133-18-3 (anhydrous, citrate)"@fr, "94133-18-3 (anhydrous, citrate)"@en, "Acide énalaprilique"@fr ; dc:modified "2018-05-21"^^xsd:date ; skos:hiddenLabel "Pres iv"@en, "MK 422"@fr, "Enalaprilat, (R)-Isomer, Anhydrous"@en, "Citrate d'énalaprilate anhydre"@fr, "1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline dihydrate"@en, "Enalaprilat Anhydrous"@en, "MK422"@fr, "Xanef"@en, "Énalaprilate anhydre"@fr, "Enalaprilat Dihydrate"@en, "Enalaprilic Acid"@en, "Vasotec"@en, "MK-422"@fr, "MK-422"@en, "Enalaprilat Citrate, Anhydrous"@en ; mesh:allowableQualifier jvr:-S0CS1X5R-5, jvr:-T9HQD7ST-J, jvr:-XV06LPML-W, jvr:-R0ZCQ8X6-J, jvr:-R3QWLHRG-V, jvr:-NFTHND7Q-8, jvr:-W6SQV79N-S, jvr:-D0F21513-5, jvr:-HQRFT0C6-B, jvr:-H7K65Q8S-Z, jvr:-FWD2BGQ0-9, jvr:-NB0XHT3S-N, jvr:-G30ZJ446-J, jvr:-NKM836P1-M, jvr:-CB30NGKB-3, jvr:-BT300B3G-Q, jvr:-NHL3D2X0-S, jvr:-SBNWSM1T-R, jvr:-L6C0XPHT-4, jvr:-WK5F724J-1, jvr:-M63HSDM7-1, jvr:-TJHVZCRZ-0, jvr:-Q3979798-W, jvr:-G4R176S9-J, jvr:-THHNVC7V-3 ; skos:broader jvr:-NR94SJDS-1 ; mesh:pharmacologicalAction jvr:-FG8LP9J8-Q, jvr:-PCSM8M59-2 ; skos:inScheme jvr: ; dc:established "1990-01-01"^^xsd:date ; owl:sameAs ; a skos:Concept, mesh:Descriptor ; skos:definition "The active metabolite of ENALAPRIL and one of the potent, intravenously administered, ANGIOTENSIN-CONVERTING ENZYME INHIBITORS. It is an effective agent for the treatment of essential hypertension and has beneficial hemodynamic effects in heart failure. The drug produces renal vasodilation with an increase in sodium excretion."@en ; skos:prefLabel "Enalaprilat"@en, "Énalaprilate"@fr ; dc:created "1989-07-19"^^xsd:date . jvr:-NKM836P1-M skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-PCSM8M59-2 skos:prefLabel "Angiotensin-Converting Enzyme Inhibitors"@en, "Inhibiteurs de l'enzyme de conversion de l'angiotensine"@fr ; a mesh:Descriptor, skos:Concept . jvr:-WK5F724J-1 skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept .